Pradaxa Lawsuit – d’Oliveira & Associates

Boehringer Ingelheim’s anticoagulant (“blood thinner’) drug Pradaxa tops all others on the Food and Drug Administration’s (FDA) list of deaths reported in 2011, with 542 total. Pradaxa is the first oral treatment for atrial fibrillation, an irregular heartbeat that may increase the risk of stroke, since Coumadin (Warfarin) was introduced in the 1950s. Boehringer Ingelheim marketed Pradaxa to be the more convenient, superior alternative to Warfarin. However, since its approval by the FDA in late 2010, the number of severe complications resulting from Pradaxa is nearly 4,000. Though the number of patients who were prescribed Pradaxa in 2011 is comparable to the number prescribed Warfarin, the number of deaths reported to the FDA resulting from Pradaxa vs Warfarin was 542-72.

Pradaxa Creates Life-Threatening Risk of Internal Bleeding

Of the numerous side effects resulting from Pradaxa, the most common and most serious is the risk of internal bleeding. With the traditional treatment of Warfarin, bleeding can be stopped with Vitamin K. With Pradaxa however, there is no antidote to stop the bleeding. This deadly side effect may result in internal bleeding and can be fatal. In fact, studies have shown incidents of Pradaxa being linked to death resulting from internal bleeding and bleeding in the brain. The result has been numerous claims and Pradaxa lawsuits filed against the manufacturer.


Have You or a Loved One Suffered from the use of Pradaxa?

If you or a loved one have had internal bleeding, heart damage, or developed a serious side effect while on the blood thinning medication Pradaxa, you may want to speak with a Rhode Island attorney regarding a potential Pradaxa lawsuit. d’Oliveira & Associates is working with some of the leading dangerous drug lawyers in the country who are handling these cases. Please contact the law offices of d’Oliveira & Associates, at 1-800-992-6878 or fill out a contact form for a free legal consultation.